These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 28359406

  • 1. The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma.
    Xu JZ, Wen F, Wang XR.
    Kaohsiung J Med Sci; 2017 Apr; 33(4):187-194. PubMed ID: 28359406
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
    Zidi S, Sghaier I, Gazouani E, Mezlini A, Yacoubi-Loueslati B.
    Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
    [Abstract] [Full Text] [Related]

  • 3. Correlations of Galectin-3 Gene Polymorphisms with Risk and Prognosis of Cervical Cancer in Chinese Populations: A Case-Control Study.
    Fang SQ, Feng YM, Li M.
    Oncol Res Treat; 2017 Apr; 40(9):533-539. PubMed ID: 28848207
    [Abstract] [Full Text] [Related]

  • 4. [eIF3a gene polymorphism and chemo-sensitivity to platinum-based drugs in ovarian cancer].
    Zhang C, Zhang S, Liu Y, Tian Y, Li X, Zhang Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):617-22. PubMed ID: 26164510
    [Abstract] [Full Text] [Related]

  • 5. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
    Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A.
    Cancer Detect Prev; 2007 Jun; 31(2):102-9. PubMed ID: 17418979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Relationship between polymorphism of hypoxia inducible factor-1alpha and cervical cancer in Han population in Sichuan Province of China].
    Chai D, Chen YL, Zheng A, Liu YY, Chu YX, Han L.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):674-7. PubMed ID: 20848794
    [Abstract] [Full Text] [Related]

  • 8. ERCC1 C19007T polymorphism and the risk and invasiveness of cervical cancer in Korean women.
    Han SS, Kim JW, Lee SH, Kim DH, Park NH, Song YS, Kang SB.
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):e63-7. PubMed ID: 22897321
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Correlation of polymorphism of Nme1-1465 T>C and TGFβ1-509 T>C with genetic susceptibility of gastric carcinoma].
    Lin XD, Li C, Shi Y, Chen Y, Zhang LY, Zheng XW.
    Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):681-5. PubMed ID: 21176535
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
    Fujiwara M, Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Sumida I, Hayashi K, Kimura T, Ogawa K.
    J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
    [Abstract] [Full Text] [Related]

  • 14. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population.
    Pawlak E, Karabon L, Wlodarska-Polinska I, Jedynak A, Jonkisz A, Tomkiewicz A, Kornafel J, Stepien M, Ignatowicz A, Lebioda A, Dobosz T, Frydecka I.
    Hum Immunol; 2010 Feb; 71(2):195-200. PubMed ID: 19913589
    [Abstract] [Full Text] [Related]

  • 15. Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.
    Yin JY, Meng XG, Qian CY, Li XP, Chen J, Zheng Y, Liu R, Zhou HH, Liu ZQ.
    Acta Pharmacol Sin; 2015 Mar; 36(3):375-84. PubMed ID: 25732572
    [Abstract] [Full Text] [Related]

  • 16. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
    Lin XD, Chen G, Li C, Zhang LY, Shi Y, Zhou DM, Zheng XW.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
    [Abstract] [Full Text] [Related]

  • 17. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y, Ren YK, Cheng HJ, Wang L, Luo SX.
    Int J Clin Exp Pathol; 2015 Aug; 8(5):5273-81. PubMed ID: 26191228
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the association of HOTAIR single nucleotide polymorphism (rs920778) and risk of cervical cancer.
    Qiu H, Liu Q, Li J, Wang X, Wang Y, Yuan Z, Li J, Pei DS.
    APMIS; 2016 Jul; 124(7):567-73. PubMed ID: 27229487
    [Abstract] [Full Text] [Related]

  • 19. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer.
    Lee J, Kim TH, Kim GE, Keum KC, Kim YB.
    J Gynecol Oncol; 2016 Sep; 27(5):e52. PubMed ID: 27329200
    [Abstract] [Full Text] [Related]

  • 20. [CDH1 polymorphism and its association with the risk of cervical cancer].
    Zhou RM, Wang N, Sun DL, Duan YN, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):56-9. PubMed ID: 19563064
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.